Grafeel 300 mcg PFS

Product Description

Grafeel 300 mcg injection is a synthetic version of the human granulocyte colony-stimulating factor (G-CSF), designed to promote the production of white blood cells in patients undergoing chemotherapy for cancer treatment. By enhancing the bodys ability to generate these vital immune cells, Grafeel significantly lowers the risk of infections that can arise during such aggressive therapies. This medication is specifically beneficial for cancer patients, helping to manage the side effects of chemotherapy. However, it is important to note that individuals with certain blood disorders should avoid using Grafeel due to potential complications. Common side effects may include mild flu-like symptoms, which typically resolve as the body adjusts to the medication. Always consult a healthcare professional before starting treatment to ensure it aligns with your medical history and current health status. With its targeted action, Grafeel 300 mcg injection plays a crucial role in supporting patients through their cancer treatment journey, fostering a more robust immune response.